Company Profile

Novartis AG

Lichtstrasse 35

Basel CH-4056 Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001

Industry
Services

Segment
Medical Device - Biomaterials

Company News

Novartis AG (NVS) Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz, Inc. 3/6/2015 7:46:53 AM

Novartis AG (NVS)'s Sandoz Bags Approval for First Biosimilar to be Sold in the U.S. 3/6/2015 7:44:03 AM

Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million 3/5/2015 6:08:11 AM

Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO 3/4/2015 6:22:11 AM

Radius (RDUS) Appoints Former Novartis AG (NVS) Executive Tony Rosenberg To Board Of Directors 3/2/2015 7:57:36 AM

Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective 3/2/2015 7:20:14 AM

European Medicines Agency Release: Novartis AG (NVS)'s Zykadia Recommended For Approval In Advanced Non Small Cell Lung Cancer 2/27/2015 9:31:17 AM

Novartis AG (NVS) Japan Ordered to Halt Business for 15 Days 2/27/2015 5:59:46 AM

Novartis AG (NVS) Heir Sues German Nobleman and Rothchild Bank 2/24/2015 6:12:45 AM

//-->